The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.20
Bid: 50.40
Ask: 51.20
Change: 0.80 (1.59%)
Spread: 0.80 (1.587%)
Open: 51.00
High: 51.20
Low: 50.00
Prev. Close: 50.40
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re Pensions

7 Dec 2015 07:00

RNS Number : 1269I
Renold PLC
07 December 2015
 

Renold plc

("Renold" or "the Company" or "the Group")

 

Re: Lowering risk and reducing liabilities for pension schemes

 

Renold, a leading international supplier of industrial chains and related power transmission products, announces further actions to reduce and de-risk pension liabilities in the UK and Germany.

 

UK: Second medically underwritten insured buy-in

The Renold Pension Scheme (the Group's UK legacy Defined Benefit pension scheme, 'the RPS') has completed a second medically underwritten insured buy-in that fully de-risks another £27m (approximately 25%) of the current UK pensioner liabilities (1) and follows a similar transaction in April 2015. Both transactions were in respect of the highest risk pensioner members (2) and the transaction announced today results in approximately 50% of current UK pensioner liabilities being fully de-risked.

 

Similarly attractive pricing terms were obtained compared to the April transaction and hence the RPS was again able to secure the liabilities at a small discount to their assumed funding valuation. As a result, the transaction has improved the funding level of the RPS in addition to the further reduction in risk. The transaction is broadly neutral from an accounting valuation perspective and was structured as a 'buy-in' and hence the insurance policy remains an asset of the scheme. Consideration for the buy-in will be sourced entirely from a portion of the scheme's holding of high quality corporate bonds. The Group has agreed that a modest acceleration of up to £1.0m of contingent cash contributions that would have been payable in the financial year ending March 2018, will be made in the financial year ending March 2017.

 

The Group is now fully protected against risks arising from volatility in longevity, inflation and interest rates in respect of these members. These factors will be relevant to future triennial revaluations and funding discussions with Trustees.

 

Closure of unfunded German pension scheme to future accrual

A German court has confirmed that the pension scheme of the Group's subsidiary in Germany was properly closed to future accrual with effect from 30 September 2013. This is expected to result in a reduction in the Group's unfunded pension obligations of approximately 6.0% or £1.5m, based on market conditions and exchange rates as at 30 September 2015 and will be fully disclosed in the Group's Annual Report and Accounts for the year ending 31 March 2016. The confirmed closure also reduces annual service costs as well as eliminating the German scheme's exposure to the risk of salary inflation.

 

Robert Purcell, Chief Executive of Renold, commented:

 

"These actions significantly reduce and further de-risk our pension liabilities in the UK and Germany. At the same time, they lower future funding costs and thus protect the Group's ability to invest further in the business. They are also important milestones in rebuilding the Group's balance sheet and delivering sustainable gains in shareholder value."

 

7 December 2015

 

(1) Liabilities assessed on a scheme funding basis

(2) High liability members from a scheme perspective are those with higher annual pension incomes who represent a significant concentration of longevity risk for the scheme.

 

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Finance Director

Instinctif

020 7457 2020

Mark Garraway

Helen Tarbet

 

 

 

 

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNUWRVKAURAA
Date   Source Headline
8th Jul 20227:00 amRNSInvestor presentation
17th Jun 20227:00 amRNSBlock Listing Six Monthly Return
18th May 202212:18 pmRNSPreference Stock Dividend
4th May 20227:00 amRNSAppointment of Non-Executive Director
19th Apr 20223:53 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Update and Notice of Results
2nd Feb 20224:35 pmRNSPrice Monitoring Extension
25th Jan 20229:23 amRNSHolding(s) in Company
20th Jan 20224:42 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
20th Dec 202111:10 amRNSHolding(s) in Company
17th Dec 20218:43 amRNSBlock Listing Six Monthly Return
29th Nov 20213:15 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSInterim Results
8th Nov 20217:00 amRNSPreference Stock Dividend
5th Nov 20217:00 amRNSAppointment of Joint Broker
2nd Nov 202111:07 amRNSHolding(s) in Company
1st Nov 20211:04 pmRNSHolding(s) in Company
27th Oct 20217:00 amRNSNotice of Interim Results
20th Oct 20213:48 pmRNSHolding(s) in Company
31st Aug 202111:50 amRNSHolding(s) in Company
25th Aug 20217:00 amRNSHolding(s) in Company
23rd Aug 202112:11 pmRNSResult of AGM
23rd Aug 20217:00 amRNSAGM Trading Update
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
29th Jul 20214:41 pmRNSSecond Price Monitoring Extn
29th Jul 20214:36 pmRNSPrice Monitoring Extension
28th Jul 20217:00 amRNSPosting of Annual Report and Notice of AGM
27th Jul 202112:50 pmRNSDirector/PDMR Shareholding
26th Jul 20218:55 amRNSGrant of Options
19th Jul 202111:23 amRNSDirector/PDMR Shareholding
16th Jul 20217:00 amRNSFinal Results
13th Jul 20217:00 amRNSFlexible Coupling Contract Award
8th Jul 20219:47 amRNSNotice of results for the year ended 31 March 2021
23rd Jun 20213:30 pmRNSHolding(s) in Company
18th Jun 20217:00 amRNSBlock listing Six Monthly Return
16th Jun 20217:00 amRNSNotice of results for the year ended 31 March 2021
15th Jun 20214:40 pmRNSSecond Price Monitoring Extn
15th Jun 20214:35 pmRNSPrice Monitoring Extension
11th Jun 20217:00 amRNSInvestor Presentation – 17 June 2021
28th May 202112:35 pmRNSNotice of Results
27th May 20214:02 pmRNSCapital Reduction
26th May 20218:30 amRNSPreference Stock Dividend
4th May 202110:38 amRNSHolding(s) in Company
15th Apr 20215:27 pmRNSResults of General Meeting
14th Apr 20217:00 amRNSTrading Update for the year ended 31 March 2021
29th Mar 20218:40 amRNSNotice of General Meeting
24th Feb 20215:17 pmRNSHolding(s) in Company
9th Feb 20214:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.